Fusion Acquisition Corp. (FUSE.U), filed for a $250 million IPO last night, and will be focused on companies with an enterprise value of approximately $750 million to $3 billion and with a particular emphasis on companies in the FinTech sector.
The Fusion team will be led by Jim Ross, as non-Executive Chairman, and John James, as CEO. For those unfamiliar with Mr. Ross, he is currently a senior advisor to State Street, the financial services company, but he is best known for being the Chairman of the global SPDR exchange-traded fund (“SPDR ETF”). He is an ETF pioneer having helped bring the first Gold ETF to market (GLD), as well as SPY, which are probably the most recognizable ETFs. However, as his bio in the prospectus states, “Mr. Ross was also instrumental in creating, developing, and bringing to market many of the world’s first ETFs“.
As for Mr. James, Fusion’s CEO, he most recently founded BetaSmartz, a global financial technology business serving financial services organizations, in 2015, and has served as its chairman and chief executive officer since November 2015. Rounding out the team are Jeffrey Gary, who will be Fusion’s CFO, and the Directors, Kelly Driscoll and Ben Buettell. All of whom have significant financial services experience. Mr. Gary – portfolio manager at Avenue Capital and Blackrock, Ms. Driscoll – State Street; Mr. Buettell – Houlihan Lokey. So clearly, this team has financial services experience.
Looking at this SPAC’s structure, it’s a fairly standard structure we used to see quite frequently last year. That is, it’s a $250 million, 1/2 warrant, 18 months life SPAC, with a $7.0 million at-risk purchase of warrants at $1.00. No forward purchases, or indications of interest, just a straight-up SPAC. Plus, they have Cantor underwriting the deal (with Odeon Capital as co-manager) and Cantor tends to favor simpler structures without a lot of bells and whistles.
All told, this SPAC should price pretty easily. They have an experienced underwriter, and the terms feel like a good match for this first time team. Look for Fusion to price the week of June 22nd.
Summary of terms below:
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...
In June 2025, the SPAC market was marked by a notable rise in meeting delays, with adjournments and postponements playing a central role in extension activity, as sponsors navigated a more cautious market environment. Still, several SPACs secured shareholder approvals, and seven business combinations were completed during the month. At the same time, IPO issuance...
An In-Depth Look at SPAC Activity Through the Second Quarter & First Half 2025 Below is a summary of the first half of 2025 SPAC market. If you’d like a pdf copy, you can access the link HERE. Q2 kicked off in chaos. President Trump’s shifting and often contradictory tariff announcements sent markets reeling, driving...
At the SPAC of Dawn The market is set to be showered with new SPACs today as three more SPACs priced their IPOs overnight, bringing 2025’s total to 66, already surpassing the full-year total of 2024. After hours, Ribbon (NASDAQ:RIBB) also added a new SPAC deal to June’s tally just under the wire, bringing the...
NMP Acquisition Corp. (NASDAQ:NMPAU) announced the pricing of its $100 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “NMPAU”, Tuesday, July 1, 2025. The new SPAC plans to combine with a target company that has a resilient business model with potential to scale up revenue. NMP’s management...